Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep 16:35:e2507019.
doi: 10.4014/jmb.2507.07019.

Automated and Programmable Cell-Free Systems for Scalable Synthetic Biology with a Focus on Biofoundry Integration

Affiliations
Review

Automated and Programmable Cell-Free Systems for Scalable Synthetic Biology with a Focus on Biofoundry Integration

Ji-Su Jun et al. J Microbiol Biotechnol. .

Abstract

Cell-free protein synthesis (CFPS) has been used as a transformative technology in synthetic biology, providing a programmable, scalable, and automation-compatible platform for biological engineering. Freed from the limitations of cell viability and growth, CFPS enables rapid design iteration, precise control of reaction conditions, and high-throughput experimentation. Recent integration of CFPS with biofoundries-automated, high-throughput biological engineering platforms-has dramatically accelerated the Design-Build-Test-Learn cycle, facilitating applications such as enzyme engineering, metabolic pathway prototyping, biosensor development, and remote biomanufacturing. Advances in automation technologies, including liquid-handling robotics and digital microfluidics, have further enhanced the scalability and reproducibility of CFPS workflows. Additionally, coupling CFPS with machine learning has enabled predictive optimization of genetic constructs and biosynthetic systems. This review highlights the technological innovations driving the convergence of CFPS and automated biofoundries, outlining current capabilities, challenges, and future directions toward programmable, scalable, and distributed biological engineering.

Keywords: Cell-free protein synthesis; automation; biofoundry; high-throughput screening; programmable biological engineering; synthetic biology.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have no financial conflicts of interest to declare.

Figures

Fig. 1
Fig. 1. Major components of cell-free protein synthesis (CFPS).
A CFPS reaction consists of DNA templates, transcription (TX)-translation (TL) machineries, nucleotides, amino acids, energy regeneration systems, and cofactors/buffers. These elements work together in cell-free environments to drive gene expression independent of living cells.
Fig. 2
Fig. 2. General applications of CFPS.
CFPS supports a broad range of applications, including metabolic pathway prototyping, enzyme engineering, antibody screening, genetic circuit testing, and biosensor development. Its open and tunable environment enables rapid and flexible prototyping across synthetic biology, diagnostics, and biomanufacturing.
Fig. 3
Fig. 3. Integration of CFPS into the Design-Build-Test-Learn (DBTL) cycle.
CFPS enables rapid prototyping and high throughput testing within the DBTL workflow by decoupling gene expression from living cells. Its compatibility with automation, programmability, and reproducibility accelerates synthetic biology research and biofoundry operations.

References

    1. Endy D. Foundations for engineering biology. Nature. 2005;438:449–453. doi: 10.1038/nature04342. - DOI - PubMed
    1. Khalil AS, Collins JJ. Synthetic biology: applications come of age. Nat. Rev. Genet. 2010;11:367–379. doi: 10.1038/nrg2775. - DOI - PMC - PubMed
    1. Weber W, Fussenegger M. Emerging biomedical applications of synthetic biology. Nat. Rev. Genet. 2012;13:21–35. doi: 10.1038/nrg3094. - DOI - PMC - PubMed
    1. Katz L, Chen YY, Gonzalez R, Peterson TC, Zhao H, Baltz RH. Synthetic biology advances and applications in the biotechnology industry: a perspective. J. Ind. Microbiol. Biotechnol. 2018;45:449–461. doi: 10.1007/s10295-018-2056-y. - DOI - PubMed
    1. Kwon KK, Lee J, Kim H, Lee D-H, Lee S-G. Advancing high-throughput screening systems for synthetic biology and biofoundry. Curr. Opin. Syst. Biol. 2024;37:100487. doi: 10.1016/j.coisb.2023.100487. - DOI